It will allow an uplist to NASDAQ / NYSE if and when govt grants come ($4.00 minimum share price required).
Given that Fidson already purchased pills in Q4 2018 (prob enough for 1000 people, 6 month test run IMO), I would you say it is HIGHLY LIKELY that govt agencies are reviewing the Lodonal results with Fidson right now. Why wouldn’t they AT LEAST review the results? What exactly is wrong with Lodonal that PEPFAR wouldn’t AT LEAST review the results? IMO, there’s less than 1% chance that Lodonal’s results are not currently being reviewed.
And oh yeah, THE FACT that she never issued a press release telling investors about shipping the 250 K pills to FIDSON makes it much more likely that grants are indeed coming. ONE MUST ASK ONESELF WHY THERE WAS NOT A PAID STOCK PROMOTION FOR THIS. Hmm, maybe to get cheap warrants and preferred shares for insiders BEFORE THEY PROMOTE IT WHEN GRANTS GET HERE IMO.
If there is anything at all that I said that you disagree with, please respond with an explanation of exactly what and why you disagree with.